AU2016282863B2 - Drospirenone-based contraceptive for a female patient affected with excess weight - Google Patents

Drospirenone-based contraceptive for a female patient affected with excess weight Download PDF

Info

Publication number
AU2016282863B2
AU2016282863B2 AU2016282863A AU2016282863A AU2016282863B2 AU 2016282863 B2 AU2016282863 B2 AU 2016282863B2 AU 2016282863 A AU2016282863 A AU 2016282863A AU 2016282863 A AU2016282863 A AU 2016282863A AU 2016282863 B2 AU2016282863 B2 AU 2016282863B2
Authority
AU
Australia
Prior art keywords
drospirenone
daily
contraceptive
drsp
women
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016282863A
Other languages
English (en)
Other versions
AU2016282863A1 (en
Inventor
Cecile Boyer-Joubert
Dominique Drouin
Philippe Perrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Leon Farma SA
Original Assignee
Laboratorios Leon Farma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56178376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2016282863(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CN201510348953.1A external-priority patent/CN106265694A/zh
Priority claimed from EP15305965.4A external-priority patent/EP3108889A1/en
Application filed by Laboratorios Leon Farma SA filed Critical Laboratorios Leon Farma SA
Publication of AU2016282863A1 publication Critical patent/AU2016282863A1/en
Application granted granted Critical
Publication of AU2016282863B2 publication Critical patent/AU2016282863B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2016282863A 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight Active AU2016282863B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201510348953.1A CN106265694A (zh) 2015-06-23 2015-06-23 用于过重女性患者的基于屈螺酮的避孕药
EP15305965.4A EP3108889A1 (en) 2015-06-23 2015-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight
CN201510348953.1 2015-06-23
EP15305965.4 2015-06-23
PCT/EP2016/064574 WO2016207298A1 (en) 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight

Publications (2)

Publication Number Publication Date
AU2016282863A1 AU2016282863A1 (en) 2018-02-08
AU2016282863B2 true AU2016282863B2 (en) 2021-05-27

Family

ID=56178376

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016282863A Active AU2016282863B2 (en) 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight

Country Status (26)

Country Link
EP (1) EP3313408B1 (OSRAM)
JP (1) JP6827962B2 (OSRAM)
KR (1) KR102217942B1 (OSRAM)
CN (2) CN108025014B (OSRAM)
AU (1) AU2016282863B2 (OSRAM)
BR (1) BR112017028048A2 (OSRAM)
CA (1) CA2989975C (OSRAM)
DK (1) DK3313408T3 (OSRAM)
EA (1) EA036497B1 (OSRAM)
ES (1) ES2970532T3 (OSRAM)
FI (1) FI3313408T3 (OSRAM)
HR (1) HRP20240121T8 (OSRAM)
HU (1) HUE065350T2 (OSRAM)
LT (1) LT3313408T (OSRAM)
MX (1) MX389310B (OSRAM)
MY (1) MY187233A (OSRAM)
NI (1) NI201700173A (OSRAM)
PH (1) PH12017502379A1 (OSRAM)
PL (1) PL3313408T3 (OSRAM)
RS (1) RS65196B1 (OSRAM)
SI (1) SI3313408T1 (OSRAM)
SM (1) SMT202400062T1 (OSRAM)
SV (1) SV2017005602A (OSRAM)
UA (1) UA122873C2 (OSRAM)
WO (1) WO2016207298A1 (OSRAM)
ZA (1) ZA201800067B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
MY195019A (en) 2015-06-18 2023-01-03 Estetra Sprl Orodispersible dosage unit containing an estetrol component
MD3310346T2 (ro) 2015-06-18 2021-06-30 Estetra Sprl Comprimată orodispersabilă ce conține estetrol
JP6866560B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
HUE054589T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Szájban diszpergálódó esztetrol tartalmú tabletta
MX389310B (es) 2015-06-23 2025-03-20 Laboratorios Leon Farma Sa Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso.
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012000981A1 (en) * 2010-06-29 2012-01-05 Laboratorios Leon Farma Sa Pharmaceutical composition comprising drospirenone and contraceptive kit

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
WO2004041288A1 (en) * 2002-11-05 2004-05-21 Schering Aktiengesellschaft Hormone replacement therapy with drospirenone
CN107875388A (zh) * 2004-04-30 2018-04-06 拜耳知识产权有限责任公司 对延长的激素避孕方案中突破性出血的控制
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
EP1773344A1 (en) * 2004-07-07 2007-04-18 Wyeth a Corporation of the State of Delaware Cyclic progestin regimens and kits
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
ATE403668T1 (de) 2005-07-21 2008-08-15 Bayer Schering Pharma Ag Verfahren zur herstellung von 3-oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie oxidation von 17-(3-hydroxypropyl)-3,17- dihydroxyandrostanen
MX2009010763A (es) * 2007-04-05 2009-10-28 Bayer Schering Pharma Ag NUEVO REGIMEN DE DROSPIRENONA/17ß-ESTRADIOL, PRODUCTO FARMACEUTICO COMBINADO Y CONJUNTO DE ELEMENTOS (KIT) PARA SU APLICACION.
EP2548881B1 (en) * 2010-03-16 2014-12-17 Taizhou Taifa Pharmaceuticals Co., Ltd Preparation method of drospirenone
RU2422824C1 (ru) * 2010-05-07 2011-06-27 Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Способ выбора тактики лечения нарушений менструального цикла у девочек-подростков с избыточной массой тела
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
CN103372015A (zh) * 2012-04-19 2013-10-30 国家人口计生委科学技术研究所 包含屈螺酮或屈螺酮和雌激素的阴道环制剂
RU2527357C1 (ru) * 2013-08-02 2014-08-27 Государственное бюджетное образовательное Учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (МГМСУ имени А.И. Евдокимова" Минздрава России) Способ персонифицированной профилактики эстрогензависимых заболеваний у здоровых женщин и женщин с факторами сердечно-сосудистого риска в возрасте 45-60 лет
MX389310B (es) 2015-06-23 2025-03-20 Laboratorios Leon Farma Sa Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012000981A1 (en) * 2010-06-29 2012-01-05 Laboratorios Leon Farma Sa Pharmaceutical composition comprising drospirenone and contraceptive kit

Also Published As

Publication number Publication date
SV2017005602A (es) 2018-08-14
KR102217942B1 (ko) 2021-02-19
WO2016207298A1 (en) 2016-12-29
CN113750108B (zh) 2025-08-19
EA201792595A1 (ru) 2018-06-29
CN108025014A (zh) 2018-05-11
EP3313408B1 (en) 2023-12-06
ES2970532T3 (es) 2024-05-29
UA122873C2 (uk) 2021-01-13
HUE065350T2 (hu) 2024-05-28
HRP20240121T1 (hr) 2024-04-12
DK3313408T3 (da) 2024-01-29
PH12017502379A1 (en) 2018-06-25
AU2016282863A1 (en) 2018-02-08
SI3313408T1 (sl) 2024-04-30
MX389310B (es) 2025-03-20
BR112017028048A2 (pt) 2018-09-04
NI201700173A (es) 2018-04-02
JP2018527305A (ja) 2018-09-20
SMT202400062T1 (it) 2024-03-13
CN108025014B (zh) 2021-10-22
MX2017016801A (es) 2018-05-11
JP6827962B2 (ja) 2021-02-10
CN113750108A (zh) 2021-12-07
EP3313408A1 (en) 2018-05-02
FI3313408T3 (fi) 2024-01-25
HRP20240121T8 (hr) 2024-05-10
PL3313408T3 (pl) 2024-04-15
LT3313408T (lt) 2024-03-12
NZ739195A (en) 2024-04-26
RS65196B1 (sr) 2024-03-29
CA2989975A1 (en) 2016-12-29
EA036497B1 (ru) 2020-11-17
CA2989975C (en) 2021-10-12
ZA201800067B (en) 2019-07-31
HK1255216A1 (zh) 2019-08-09
KR20180019173A (ko) 2018-02-23
MY187233A (en) 2021-09-13

Similar Documents

Publication Publication Date Title
AU2016282863B2 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
US11291633B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
US11951213B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
US10179140B2 (en) Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US20220192991A1 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
EP3108889A1 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
HK40061928A (en) Drospirenone-based contraceptive for a female patient affected with excess weight
OA18512A (en) Drospirenone-based contraceptive for a female patient affected with excess weight.
HK40061928B (zh) 用於过重女性患者的基於屈螺酮的避孕药
AU2011273605B8 (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
HK1232778A (en) Drospirenone-based contraceptive for a female patient affected with excess weight
HK1232778A1 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
CN106265694A (zh) 用于过重女性患者的基于屈螺酮的避孕药
HK1255216B (zh) 用於过重女性患者的基於屈螺酮的避孕药

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)